These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7654733)

  • 1. Paramyxovirus infection in lung transplant recipients.
    Wendt CH; Fox JM; Hertz MI
    J Heart Lung Transplant; 1995; 14(3):479-85. PubMed ID: 7654733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH; Hertz MI
    Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.
    Gottlieb J; Schulz TF; Welte T; Fuehner T; Dierich M; Simon AR; Engelmann I
    Transplantation; 2009 May; 87(10):1530-7. PubMed ID: 19461490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parainfluenza virus respiratory infection after bone marrow transplantation.
    Wendt CH; Weisdorf DJ; Jordan MC; Balfour HH; Hertz MI
    N Engl J Med; 1992 Apr; 326(14):921-6. PubMed ID: 1311800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections.
    Fuehner T; Dierich M; Duesberg C; DeWall C; Welte T; Haverich A; Warnecke G; Simon AR; Gottlieb J
    Antivir Ther; 2011; 16(5):733-40. PubMed ID: 21817195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
    Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
    Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
    Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.
    Elizaga J; Olavarria E; Apperley J; Goldman J; Ward K
    Clin Infect Dis; 2001 Feb; 32(3):413-8. PubMed ID: 11170949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of parainfluenza virus infection in lung transplant recipients.
    Vilchez RA; McCurry K; Dauber J; Iacono A; Keenan R; Zeevi A; Griffith B; Kusne S
    Clin Infect Dis; 2001 Dec; 33(12):2004-8. PubMed ID: 11702289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
    McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
    Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus pneumonia in a lung transplant recipient: case report.
    Doud JR; Hinkamp T; Garrity ER
    J Heart Lung Transplant; 1992; 11(1 Pt 1):77-9. PubMed ID: 1540615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
    McCurdy LH; Milstone A; Dummer S
    J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
    El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
    Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
    J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.